Table 2.
Longevity | Control | 95%CI | |||||
---|---|---|---|---|---|---|---|
n = 307(100%) | n = 486 (100%) | χ2 | OR | Lower | Upper | P | |
AOB | 17.3% | 13.6% | 2.002 | 0.753 | 0.508 | 1.116 | 0.157 |
Elevated BP | 61.1% | 38.9% | 183.15 | 0.106 | 0.075 | 0.150 | <.001 |
RFG | 39.1% | 7.2% | 121.65 | 0.121 | 0.080 | 0.183 | <.001 |
highTG | 21.8% | 35.6% | 16.910 | 1.980 | 1.426 | 2.749 | <.001 |
lowHDL-C | 33.2% | 10.7% | 61.005 | 0.241 | 0.166 | 0.350 | <.001 |
MetS | 28.0% | 5.1% | 81.740 | 0.139 | 0.087 | 0.224 | <.001 |
95%CI 95% Confidence Interval, AOB abdominal obesity, Elevated BP elevated blood pressure, RFG raised fasting glucose, highTG high triglyceride, low HDL-C low high-density lipoprotein cholesterol, MetS metabolic syndrome